Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose-ranging TAP block trial after cesarean section
ChiCTR2400081531Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, People's Hospital of Ningxia Hui Autonomous Region
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine, dexamethasone and ropivacaine in postoperative pain (3 arms), sponsored by Department of Anesthesiology, People's Hospital of Ningxia Hui Autonomous Region. Primary endpoints: VAS pain scores at rest and VAS pain scores during movement. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
dexmedetomidinedexamethasoneropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400081531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081531.